Position in AVXL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$222,358
+$60,427 QoQ
Shares Held
72,430
+59.2% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. AVXL ranks #212 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in AVXL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $222,358 | 72,430 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $161,931 | 45,487 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $504,619 | 56,699 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,965,700 | 863,959 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,756,357 | 554,354 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,605,614 | 615,048 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $138,642 | 24,409 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $106,697 | 25,284 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $143,740 | 28,240 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $260,064 | 27,934 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $335,733 | 51,257 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $257,346 | 31,654 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $273,321 | 31,893 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $280,502 | 30,292 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $342,530 | 33,191 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $297,066 | 29,677 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $373,582 | 30,348 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,547,043 | 435,239 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $655,551 | 36,521 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,681,663 | 598,498 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $16,824,206 | 1,125,365 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,213,450 | 224,713 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $654,384 | 133,005 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||